Fachklinik für Neurologie Dietenbronn

Serum GFAP as a biomarker for disease severity in multiple sclerosis

Ahmed Abdelhak, André Huss, Jan Kassubek et al. · Scientific Reports · 2018 · 285 citations · Full text

Medicine, Neurology, Neuroscience +17

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

Till F. M. Andlauer, Dorothea Buck, Gisela Antony et al. · Science Advances · 2016 · 182 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

Sven Jarius, Florence Pache, Péter Körtvelyessy et al. · Journal of Neuroinflammation · 2022 · 162 citations · Full text

Medicine, Clinical Sciences, Neurology +9

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

Ahmed Abdelhak, Tilman Hottenrott, Estrella Morenas‐Rodríguez et al. · Frontiers in Neurology · 2019 · 143 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

Stefan Bittner, Falk Steffen, Timo Uphaus et al. · EBioMedicine · 2020 · 131 citations · Full text

Life Sciences, Neurology, Neuroscience +17